Royal Bank of Canada’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640K | Buy |
172,728
+172,263
| +37,046% | +$638K | ﹤0.01% | 3954 |
|
|
2025
Q1 | $1K | Sell |
465
-2,035
| -81% | -$4.38K | ﹤0.01% | 6271 |
|
|
2024
Q4 | $14K | Sell |
2,500
-2,896
| -54% | -$16.2K | ﹤0.01% | 5755 |
|
|
2024
Q3 | $59K | Buy |
5,396
+709
| +15% | +$7.75K | ﹤0.01% | 5155 |
|
|
2024
Q2 | $98K | Buy |
4,687
+2,877
| +159% | +$60.2K | ﹤0.01% | 4891 |
|
|
2024
Q1 | $57K | Sell |
1,810
-11,427
| -86% | -$360K | ﹤0.01% | 5034 |
|
|
2023
Q4 | $268K | Buy |
13,237
+6,752
| +104% | +$137K | ﹤0.01% | 4330 |
|
|
2023
Q3 | $83K | Buy |
6,485
+3,262
| +101% | +$41.8K | ﹤0.01% | 5026 |
|
|
2023
Q2 | $59K | Buy |
3,223
+1,479
| +85% | +$27.1K | ﹤0.01% | 5246 |
|
|
2023
Q1 | $30K | Sell |
1,744
-1,727
| -50% | -$29.7K | ﹤0.01% | 5482 |
|
|
2022
Q4 | $78K | Buy |
3,471
+3,036
| +698% | +$68.2K | ﹤0.01% | 5160 |
|
|
2022
Q3 | $3K | Buy |
435
+226
| +108% | +$1.56K | ﹤0.01% | 6387 |
|
|
2022
Q2 | $1K | Sell |
209
-1,547
| -88% | -$7.4K | ﹤0.01% | 6646 |
|
|
2022
Q1 | $27K | Sell |
1,756
-3,626
| -67% | -$55.8K | ﹤0.01% | 5956 |
|
|
2021
Q4 | $118K | Buy |
5,382
+3,038
| +130% | +$66.6K | ﹤0.01% | 5283 |
|
|
2021
Q3 | $63K | Buy |
2,344
+1,669
| +247% | +$44.9K | ﹤0.01% | 5506 |
|
|
2021
Q2 | $16K | Sell |
675
-38
| -5% | -$901 | ﹤0.01% | 6168 |
|
|
2021
Q1 | $31K | Buy |
+713
| New | +$31K | ﹤0.01% | 5682 |
|